Biotech Values

[EyeamBill]

NVS has some big-selling drugs too

True, and I realize you're making a deeper statement than just the easy superficial interpretation.

For instance, "Compete NVS! You're killing us!!"

SNY is defending its turf and NVS is cautiously invading; that's the only rough philosophy I can come up with to explain the apparent NVS malaise toward pricing.